Long‐Term Use of Oseltamivir for the Prophylaxis of Influenza in a Vaccinated Frail Older Population

This publication has 30 references indexed in Scilit:

• Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza
  New England Journal of Medicine, 1999
• Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802
  Clinical Pharmacokinetics, 1999
• Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza Activity
  Journal of the American Chemical Society, 1997
• Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes
  Antimicrobial Agents and Chemotherapy, 1995
• Nursing Home Outbreak of Influenza A (H3N2): Evaluation of Vaccine Efficacy and Influenza Case Definitions
  Infection Control & Hospital Epidemiology, 1992
• Emergence and Transmission of Influenza A Viruses Resistant to Amantadine and Rimantadine
  Published by Springer Nature ,1992
• Emergence and Apparent Transmission of Rimantadine-Resistant Influenza A Virus in Families
  New England Journal of Medicine, 1989
• Structure of the catalytic and antigenic sites in influenza virus neuraminidase
  Nature, 1983
• A Controlled Trial of Amantadine and Rimantadine in the Prophylaxis of Influenza a Infection
  New England Journal of Medicine, 1982
• BRIEF ASSESSMENT OF THE MENTAL STATE IN GERIATRIC DOMICILIARY PRACTICE. THE USEFULNESS OF THE MENTAL STATUS QUESTIONNAIRE
  Age and Ageing, 1973